Home -> Law Blog Directory -> Intellectual Property Law Blogs -> TinytechIP
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: TinytechIPUS Patent 7863258 - Nanoparticle cancer treatment
This patent teaches using nanoparticles for anti-cancer drug delivery in which chitosan enhances absorption. Claim 1 reads:
1. A method of treating a cancer in an animal subject comprising
administering nanoparticles consisting of an antineoplastic drug or anti-cancer therapeutic agent in effective amount to treat said cancer, positively charged chitosan, and a negatively charged substrate,
wherein a surface of said nanoparticles is dominated by the positively charged chitosan.
Full post as published by TinytechIP on January 05, 2011 (boomark / email).
FDA Review of Prostate Cancer Treatment Prompts Warning of Risk for Diabetes
Prostate Cancer Treatment FDA Review Prompts Warning of Risk for Diabetes
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Pittsburgh Cancer Center
Wanrs of Cell Phone and Cancer Risk
Health Insurance
Anorexia Treatment Not Covered
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.

Sun Pharmaceutical Industries, Ltd. v. Eli Lilly & Co. (Fed. Cir. 2010)
Glaxo tests Tykerb versus Herceptin for early Breast Cancer Treatment
NANOTECHNOLOGY UPDATE: Nanogenerator Powers Up. Other nanotechnology news: Nanoparticle gut che
Patent Profile: OncoGenex Announces Issuance of Patent for Antisense Cancer Therapeutic
Patent Agent - Small Corporation - Cambridge, Mass.







